A. Klein, M. Miesch / Tetrahedron Letters 44 (2003) 4483–4485
4485
lized for the synthesis of biologically active natural
products and analogs like for example Garsubellin A8
and Hispidospermidin9 which are respectively a poten-
tial Alzheimer’s therapeutic and a potent inhibitor of
phospholipase C (Scheme 6).
(m, 2H), 4.16 (q, J=7.1 Hz); 13C NMR (CDCl3, 75 MHz):
l 14.2, 22.9, 28.5, 28.7, 30.8, 31.9, 33.1, 38.7, 52.5, 60.8,
86.1, 91.0, 118.0, 166.4, 207.0.
Spiro derivative 5: isomer A, yellow oil; IR (CCl4): 1709,
1
1657 cm−1; H NMR (CDCl3, 300 MHz) l 1.26 (t, J=7.1
Hz, 3H), 1.50–1.90 (m, 8H), 1.95–2.15 (m, 2H), 2.25–2.65
(m, 2H), 2.90 (ddd, J=2.5 Hz, 6.7 Hz, 7.7 Hz, 2H), 4.14
(q, J=7.3 Hz, 2H), 5.67 (t, J=2.6 Hz, 1H); 13C NMR
(CDCl3, 75 MHz): l 14.3, 22.1, 22.8, 26.8, 33.0, 37.4, 38.1,
39.1, 59.6, 63.4, 114.3, 166.7, 168.3, 211.1. Spiro derivative
The scope and limitations of these cascade reactions as
well as some applications, especially the development of
new synthetic route toward Garsubellin A and Hispi-
dospermidin are currently being further investigated
and the results will be disclosed in the near further.
5: isomer B, yellow oil; IR (CCl4): 1739, 1709 cm−1
NMR (CDCl3, 300 MHz) l 1.24 (t, J=7.1 Hz, 3H), 1.50–
2.15 (m, 8H), 2.20–2.50 (m, 4H), 3.04 (ABXYZ, JA(B, C)X
;
1H
=
Acknowledgements
JA(B, C)Y=JA(B, C)Z=2.0 Hz, lA=3.18, lB=2.90, 2H),
5.77 (h, J=3.5 Hz, 2.3 Hz, 1.5 Hz, 1.3 Hz, 1H); 13C NMR
(CDCl3, 75 MHz): l 14.1, 22.1, 26.4, 29.7, 34.4, 35.6, 35.8,
39.7, 60.5, 64.6, 130.3, 138.2, 171.7, 213.2.
We thank Professor Paul Wender for stimulating dis-
cussions, Dr. Jennifer Wytko for her help in preparing
the manuscript and the CNRS and the ULP for finan-
cial support.
Diester 8: colorless oil; IR (CCl4): 1733 cm−1 1H NMR
;
(CDCl3, 300 MHz) l 1.22 (t, J=7.1 Hz, 3H), 1.23 (t,
J=7.1 Hz, 3H), 1.40 (q, J=7.7 Hz, 2H), 1.57 (quint,
J=15.9 Hz, 7.6 Hz, 7.3 Hz, 2H), 1.77 (quint, J=15.0 Hz,
7.8 Hz, 7.5 Hz, 2H), 2.07 (t, J=7.5 Hz, 2H), 2.27 (t,
J=7.5 Hz, 4H), 2.30–2.40 (m, 2H), 3.05 (s, 2H), 4.09 (q,
J=6.9 Hz, 2H), 4.10 (q, J=7.1 Hz, 2H); 13C NMR
(CDCl3, 75 MHz): l 14.2, 14.3, 21.6, 25.0, 27.4, 28.1, 34.2,
34.4, 35.5, 36.3, 60.1, 60.4, 128.1, 139.3, 171.5, 173.6.
Tricycle 9: yellow crystals mp 45–46°C; IR (CCl4): 1721,
References
1. Wendling, F.; Miesch, M. Org. Lett. 2001, 3, 2689–2691.
2. Mino, T.; Masuda, S.; Nishio, M.; Yamashita, M. J. Org.
Chem. 1997, 62, 2633–2635.
3. Barbier, M.; Hu¨gel, M. F. Bull. Chem. Soc. Fr. 1961, 60,
1324–1326.
4. Yields referred to isolated compounds. Allenes 3 and 4
were isolated as a mixture of cis isomers [3: 1 (less polar)/
0.35 (most polar); 4: 2.6 (less polar)/1 (most polar)]. Ana-
lytically pure isomers were obtained by successive medium
pressure column chromatography.
5. The spiro derivatives 5 and 6 were, respectively, isolated as
a single isomer and as a mixture of isomers (ratio: 2.6/1).
6. Carruthers, W.; Orridge, A. J. Chem. Soc., Perkin Trans. 1
1977, 2411–2416.
1
1669 cm−1; H NMR (CDCl3, 300 MHz) l 1.10–1.65 (m,
8H), 1.65–1.85 (m, 2H), 1.90–2.10 (m, 4H), 3.00–3.10 (m,
1H), 6.12 (s, 1H); 13C NMR (CDCl3, 75 MHz): l 20.4,
23.1, 25.7, 28.2, 30.7, 33.9, 39.6, 57.9, 60.5, 123.0, 171.4,
201.0, 208.8.
8. Isolation: (a) Fukuyama, Y.; Kuwayama, A.; Minami, H.
Chem. Pharm. Bull. 1997, 45, 947–949. Recent synthetic
approaches: (b) Spessard, S. J.; Stoltz, B. M. Org. Lett.
2002, 4, 1943–1946; (c) Usuda, H.; Kanai, M.; Shibasaki,
M. Org. Lett. 2002, 4, 859–862; (d) Youg, D. G.; Zeng, D.
J. Org. Chem. 2002, 67, 3134–3137; (e) Usuda, H.; Kanai,
M.; Shibasaki, M. Tetrahedron Lett. 2002, 43, 3621–3624.
9. Isolation: (a) Ohtsuka, T.; Itezono, Y.; Nakayama, N.;
Sakai, A.; Shimma, N.; Yokose, K.; Seto, H. J. Antibiot.
1994, 47, 6–15; (b) Yanagisawa, M.; Sakai, A.; Adachi, K.;
Sano, T.; Watanabe, K.; Tanaka, Y.; Okuda, T. J.
Antibiot. 1994, 47, 1–5; Total syntheses: (c) Overman, L.
E.; Tomasi, A. L. J. Am. Chem. Soc. 1998, 120, 409–4040;
(d) Frontier, A. L.; Raghavan, S.; Danishefsky, S. J. J.
Am. Chem. Soc. 2000, 122, 6151–6159; (e) Tamiya, J.;
Sorensen, E. J. J. Am. Chem. Soc. 2000, 122, 9556–9557.
7. Selected spectroscopic data: Allene 4: less polar isomer;
white crystals; mp 56–57°C; IR (CCl4): 1962, 1716 cm−1
;
1H NMR (CDCl3, 300 MHz) l 1.23 (t, J=7.1 Hz, 3H),
1.30–2.00 (m, 12H), 2.05–2.15 (m, 2H), 2.50–2.65 (m, 2H),
4.13 (ABX3, JAB=10.8 Hz, JAX=7.1 Hz, JBX=7.3 Hz,
lA=4.10, lB=4.17, 2H); 13C NMR (CDCl3, 75 MHz): l
14.2, 22.9, 28.5, 28.8, 30.7, 31.7, 32.8, 38.8, 52.8, 60.6, 86.4,
90.8, 116.8, 166.0, 207.4.
Allene 4: most polar isomer; yellow oil; IR (CCl4): 1960,
1
1716 cm−1; H NMR (CDCl3, 300 MHz) l 1.26 (t, J=7.1
Hz, 3H), 1.35–2.00 (m, 12H), 2.10–2.25 (m, 2H), 2.45–2.80